Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.545%)
Open: 45.00
High: 45.00
Low: 45.00
Prev. Close: 45.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Chamberlin loss narrows; Corero inks Latam deal

Wed, 21st Feb 2024 14:33

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Angling Direct PLC - Norfolk, England-based fishing tackle retailer - Expects annual revenue of GBP81.7 million for the year ended January 31, up 10% from GBP74.1 million the year before. This was driven by a 9.0% increase in UK sales to GBP77.4 million from GBP71.0 million the year before, and a 7.6% rise in retail store sales to GBP44.4 million from GBP41.3 million. Online sales jumped 14% to GBP37.2 million from GBP32.8 million. Chief Executive Officer Steve Crowe says: "Angling Direct has continued to gain market share in the UK and Europe, and we believe there are significant further growth opportunities in both markets. The group will continue to invest in its digital and physical footprint in the UK to capture further market share growth, leveraging its strong balance sheet to ensure it is competitively placed as consumer confidence returns. Since the period end, the UK business has completed one small footprint store acquisition in Crewe and opened one new store in Cannock, alongside committing substantial capital investment to an automated customer order packaging solution for the UK distribution centre."

----------

Rights & Issues Investment Trust PLC - Essex, England-based investor in smaller UK companies - Net asset value per share at December 31 2,337.1 pence, up 2.4% from 2,283.2p a year ago. NAV total return for 2023 was 2.4%, compared to negative 25% at the end of 2022. This is slightly lower than the FTSE All-Share index benchmark return of 3.8%. Recommends a final dividend of 31.25p per share, up from 29.25p a year prior. Total dividend is 43p, up 7.5% from 40p.

----------

Clean Power Hydrogen PLC - Doncaster, England-based green hydrogen technology and manufacturing company - Successfully completes its functional test of the programme logic control of the MFE110 system for Northern Ireland Water. The programme logic control represents the coded programme which automatically operates the MFE110 including shutdown, it says. Says the successful test was witnessed by Lagan MEICA Ltd, the contractor to Northern Ireland Water, and means the factory acceptance test can progress to the final stages. CEO Jon Duffy comments: "The successful test of the programme logic control allowing for fully automated operation, signifies an important part of the MFE110's journey to commercial production of hydrogen and medical grade oxygen. While the pausing of the FAT test in November 2023 due to issues regarding the shutdown mechanism were disappointing, I am extremely proud of the team for re-evaluating the important safety shut down measures, and successfully finding a solution which has put us back on track to completing the MFE110 for our customers in the very near-term future."

----------

Chamberlin PLC - West Midlands-based specialist castings and engineering group - Says performance for the half year ended November 30 was broadly in line with expectations. Interim pretax loss narrows to GBP78,000 from GBP467,000 a year ago. Revenue grows 1.0% to GBP10.6 million from GBP10.5 million a year prior. Looking ahead, says prospects for sustainable growth are achievable over the short to medium term. It is also moving forward with improved working capital resources in regard to its steel output. Separately, Chamberlin announces the sale of Petrel Ltd to Project Apollo Ltd for a total cash consideration of GBP3 million.

----------

Cambridge Cognition Holdings PLC - Cambridgeshire, England-based company which develops and markets digital solutions to assess brain health - Inks deal with ActiGraph for digital measurements of central nervous system trials. Chief scientist at Cambridge Cognition Francesca Cormack says: "CNS disorders are characterised by a host of heterogeneous symptoms which impact daily life, but that are often inadequately addressed by existing treatments. Our partnership with ActiGraph represents an exciting combination of expertise in objective digital measures of actigraphy, speech and cognition that will help accelerate the development of treatments for patients and improve efficiency in clinical trials."

----------

Corero Network Security PLC - London-based cybersecurity provider - Creates strategic Latin American partnership with Brazilian networks solutions distribution, TechEnabler. CEO Carl Herberger says: "Creating this strategic partnership with TechEnabler provides an ideal platform to expand our product reach in a key growth market for Corero, alongside aligning our business with a partner who shares our commitment to cybersecurity excellence. This agreement reinforces our focus on security innovation, which in turn will allow a new crop of businesses to fortify their networks against DDoS attacks whilst exploring further opportunities to leverage our cutting-edge solutions."

----------

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
20 Sep 2018 12:35

Cambridge Cognition Holdings Loss Widens As Revenue Drops

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that its loss for the first half of the financial year widened as it recorded a drop in revenue as a result of the new IFRS

Read more
19 Sep 2018 12:45

Cambridge Cognition To Provide NeuroVocalix For Virtual Clinical Tests

LONDON (Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it signed its first commercial contract with an undisclosed pharmaceutical firm for its recently launched NeuroVocalix a

Read more
19 Sep 2018 10:14

Cambridge Cognition announces first NeuroVocalix commercial partnership

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced its first commercial partnership for its recently launched 'NeuroVocalix' voice biomarker technology on Wednesday.

Read more
13 Sep 2018 11:14

Cambridge Cognition's NeuroVocalix Set For Clinical Trial Use

LONDON (Alliance News) - Neuroscience technology firm Cambridge Cognition Holdings PLC on Thursday said its NeuroVocalix platform is ready for clinical trials.NeuroVocalix, the company to a

Read more
1 Aug 2018 11:51

Cambridge Cognition Inks US Production Distribution For CANTAB

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that it signed a commercial collaboration with health provider Healthy Amplified to launch its software product to better a

Read more
17 May 2018 16:01

UK Shareholder Meetings Calendar - Next 7 Days

Friday 18 MayPaddy Power BetfairIndependent News & (T)PetrofacJohn Group (re by

Read more
22 Mar 2018 13:03

Cambridge Cognition Shares Fall As It Swings To Annual Loss

LONDON (Alliance News) - Shares fell in Cambridge Cognition Holdings PLC on Thursday as it swung to a loss in 2017 from a maiden profit due to higher costs and lower in the at

Read more
14 Mar 2018 12:47

Oil majors give in to investors with share buyback spree

By Nivedita Bhattacharjee March 14 (Reuters) - After almost three barren years for investors who have poured millions into the U.S. oil sector, producers are finally to

Read more
25 Jan 2017 08:27

Cambridge Cognition gains US regulatory approval for memory test

(ShareCast News) - Neuroscience digital health company Cambridge Cognition has gained regulatory clearance for its memory test to be used as a medical device in the US. Cantab Mobile, which detects clinically-relevant memory impairment in older adults at the point of care, received 510k clearance fo

Read more
13 Oct 2016 10:55

Cambridge Cognition confirms series of new contracts

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced a series of new contracts worth more than £0.25m on Thursday, to assess - through CANTAB Connect - the abuse potential of investigational drugs in a new market application for the company. The AIM-traded firm claimed that

Read more
22 Sep 2016 10:23

Cambridge Cognition's sales up after investments in marketing

(ShareCast News) - Cambridge Cognition' half-year revenues grew and losses were more than halved as the neuroscience software and hardware company's invested in marketing and development. For the six months ended 30 June, revenue increased by 11.3% to £3.26, compared to the same period last year. T

Read more
22 Sep 2016 08:51

Cambridge Cognition Loss Narrows On Strong Revenue Growth

Read more
20 Sep 2016 08:07

Cambridge Cognition Inks First Contract For CANTAB Recruit Product

Read more
16 Aug 2016 13:49

Cambridge Cognition announces promising results from technology study

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced results on Tuesday from a new technology feasibility study. The AIM-traded firm, which develops and markets near-patient technologies for the assessment of brain health to improve the drug development process, said the re

Read more
20 Jul 2016 07:49

Cambridge Cognition Signs GBP500,000 CANTAB Deal With Biobank

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.